IGFBP3 and metastatic melanoma: Further, increased IGFBP3 expression has also been linked to renal cell carcinoma [27], breast cancer [31,49], and metastatic melanoma [50], suggesting that IGFBP3 may contribute to tumorigenesis or disease progression.